Sunshine Biopharma - SBFM Operatsion marja

sunshinebiopharma.com (SBFM) kompaniyasining korporativ logotipi

Sunshine Biopharma kompaniyasi o'z ishlanmalarining gumanitar maqomi tufayli sanksiyalardan qochgan holda, barqaror AQSh yurisdiksiyasida faoliyat yuritadi. GURU.Markets terminali grafigidagi operatsion marja tahlili biznes samaradorligini namoyish etadi, bunda -16.80 ushbu parametrning miqdorini aks ettiradi. Daromadlar parhez qo'shimchalari savdosi va oshqozir-ichak saratoni terapiyalarini ishlab chiqishga asoslangan. Innovatsiyalar kimyoviy birikmalarni qidirishni avtomatlashtiruvchi robotlashtirilgan bio-skrining orqali tezlashmoqda.

Sunshine Biopharma Inc. (SBFM): Operatsion foyda bo'yicha sotuv rentabelligi 04.07.2022dan 19.11.2026gacha

Sunshine Biopharma - tahliliy kesimlar va asosiy koʻrsatkichlar (SBFM)

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning jamlanma tahlili:Sunshine Biopharma Inc., SBFM
Sunshine Biopharma Inc. brendining mahsuloti

Sunshine Biopharma (SBFM) uchun operatsion marjaning o'zgarishi biofarmatsevtika biznesining doimiy R&D xarajatlari sharoitida yagona molekulaning muvaffaqiyatini kengaytiriladigan foydaga aylantirish qobiliyatini namoyish etadi. Ushbu ko'rsatkich operatsion foydaning daromadga nisbati sifatida hisoblanadi va moliyaviy majburiyatlar hamda soliqlarni hisobga olguncha asosiy ishlab chiqarishning samaradorligini o'lchaydi, bu esa investorlarga biznes modelining haqiqiy daromadliligini va barqarorligini baholash imkonini beradi.

Raqobatchilar tahlili

Operatsion rentabellik BeiGene Ltd|Halozyme Therapeutics - Operatsion foyda marjasi|Sotuvning operatsion marjasi RVMD (Revolution Medicines Corp)|Operatsion foyda koeffitsiyenti AAPG|Operatsion rentabellik CG Oncology Therapeutics CGON|Operatsion foyda normasi URGN|BCAX: Sotuvning operatsion marjasi|PSNL: Operatsion rentabellik|Erasca (ERAS) - Operatsion rentabellik|DCTH - Operatsion faoliyat rentabelligi|YMAB (Y-mAbs Corp) - Operatsion marja|Sotuvning operatsion marjasi Aura Biosciences (AURA)|Operatsion rentabellik Candel Therapeutics Inc. (CADL)|Sotuvning operatsion marjasi Accuray, Inc. ARAY|Operatsion rentabellik sellaslifesciences.com SLS|Operatsion foyda normasi ACTU|CTOR - Operatsion rentabellik|Operatsion faoliyat rentabelligi tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Operatsion rentabellik|FATE: Operatsion foyda koeffitsiyenti|WHWK (Aadi Bioscience, Inc.) - Operatsion marja|TCRX (TScan Therapeutics) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Champions Oncology (CSBR)|Operatsion faoliyat rentabelligi XBiotech USA|Operatsion rentabellik CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Sotuvning operatsion rentabelligi|RADX - Operatsion rentabellik|ARTV - Operatsion marja|Adlai Nortye Ltd (ANL) - Operatsion rentabellik|Veru Pharma - Operatsion foyda normasi|Operatsion rentabellik Tempest Therapeutics Corp|Operatsion foyda bo'yicha sotuv rentabelligi XLO (Xilio Therapeutics, Inc.)|Operatsion marja RENB|MURA (Mural Oncology) - Operatsion foyda normasi|Operatsion marja KAPA (Kairos Pharma Ltd)|OKUR: Operatsion foyda bo'yicha sotuv rentabelligi|GDTC: Sotuvning operatsion marjasi|CRIS - Operatsion marja|APLM: Operatsion marja|Sotuvning operatsion rentabelligi tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Operatsion marja|Operatsion marja Genprex Inc.|Operatsion marja CLDI|Xenetic Biosciences, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Salarius Pharmaceuticals SLRX|Operatsion marja purple-biotech.com PPBT|AONC - Operatsion rentabellik|BGNE: Operatsion rentabellik|CKPT: Operatsion marja|Elevation Oncology - Operatsion foyda normasi|ICAD (iCAD) - Operatsion marja|IKNA: Operatsion foyda normasi|Operatsion rentabellik Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Operatsion foyda normasi|Operatsion rentabellik MorphoSys Corporation MOR|NAYA: Operatsion foyda bo'yicha sotuv rentabelligi|Ascentage Pharma Group International - Operatsion marja